Bi-allelic variation of<i>FANCJ</i>(<i>BRIP1</i>) identified in premature ovarian insufficiency

Objective Premature ovarian insufficiency (POI) is defined as the depletion of ovarian function before 40 years of age, affecting approximately 3.7% of women in their reproductive age worldwide. Previous studies revealed several genes involved in the Fanconi anaemia (FA) pathway participate in the pathogenesis of POI, such as FANCA and FANCM . FA pathway maintains rapid proliferation in the developing primordial germ cells by deregulating transcription-replication conflicts, which is crucial for the establishment of sufficient ovarian reserve. FANCJ encodes a DNA helicase located downstream of the FA pathway promoting DNA damage repair and cell proliferation. Recently, two heterozygous FANCJ missense variants have been reported in patients with POI, suggesting haploinsufficiency of FANCJ participates in the pathogenesis of the disease. In this study, to further explore the contribution of FANCJ variants in POI, we reported a rare homozygous FANCJ start-loss variation in one patient with POI and illustrated its pathogenicity by in vitro functional studies. Methods The loss-of-function (LoF) variants of FANCJ were screened in our internal whole-exome sequencing (WES) database of POI. Sanger sequencing and WES analysis were employed on the proband and the patient’s family members to illustrate the origin of the bi-allelic variant. Cycloheximide chase assay was performed to demonstrate the impact of the variant on the protein stability of FANCJ. Protein ubiquitination assay was performed to confirm the accelerated degradation pathway of FANCJ protein. Results Through the variation screening, a bi-allelic variant of FANCJ (NM_032043.3:c.1A&gt;G, p.Met1Val) was identified in one case. The functional study showed that the start-loss variant affected FANCJ protein stability by accelerated protein degradation through the ubiquitin-proteasome pathway. Conclusion Our findings provide further genetic evidence of the FANCJ variant participating in the pathogenesis of POI, expand the inherited mode and highlight the essential role of the FA pathway in maintaining ovarian function.

Authors

Institutions

Publication Details

Journal
Gynecology and Obstetrics Clinical Medicine
Published
2025-05-01
DOI
https://doi.org/10.1136/gocm-2025-000208
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bi-allelic variation ofFANCJ(BRIP1) identified in premature ovarian insufficiency

Hongyuan Liu, Shidou Zhao, Xue Jiao, Run-Min Yao et al.
Gynecology and Obstetrics Clinical Medicine
BRCA gene mutations in cancer
article

Bi-allelic variation ofFANCJ(BRIP1) identified in premature ovarian insufficiency

Hongyuan Liu, Shidou Zhao, Xue Jiao, Run-Min Yao, Xiaowei Wu, Maoqing Hu, Xin Liang, Ting Guo, Manting Yang, Yingying Qin, Chunmei Zhang, Xinmiao He, Aining Sun
article en

Abstract

Objective Premature ovarian insufficiency (POI) is defined as the depletion of ovarian function before 40 years of age, affecting approximately 3.7% of women in their reproductive age worldwide. Previous studies revealed several genes involved in the Fanconi anaemia (FA) pathway participate in the pathogenesis of POI, such as FANCA and FANCM . FA pathway maintains rapid proliferation in the developing primordial germ cells by deregulating transcription-replication conflicts, which is crucial for the establishment of sufficient ovarian reserve. FANCJ encodes a DNA helicase located downstream of the FA pathway promoting DNA damage repair and cell proliferation. Recently, two heterozygous FANCJ missense variants have been reported in patients with POI, suggesting haploinsufficiency of FANCJ participates in the pathogenesis of the disease. In this study, to further explore the contribution of FANCJ variants in POI, we reported a rare homozygous FANCJ start-loss variation in one patient with POI and illustrated its pathogenicity by in vitro functional studies. Methods The loss-of-function (LoF) variants of FANCJ were screened in our internal whole-exome sequencing (WES) database of POI. Sanger sequencing and WES analysis were employed on the proband and the patient’s family members to illustrate the origin of the bi-allelic variant. Cycloheximide chase assay was performed to demonstrate the impact of the variant on the protein stability of FANCJ. Protein ubiquitination assay was performed to confirm the accelerated degradation pathway of FANCJ protein. Results Through the variation screening, a bi-allelic variant of FANCJ (NM_032043.3:c.1A&gt;G, p.Met1Val) was identified in one case. The functional study showed that the start-loss variant affected FANCJ protein stability by accelerated protein degradation through the ubiquitin-proteasome pathway. Conclusion Our findings provide further genetic evidence of the FANCJ variant participating in the pathogenesis of POI, expand the inherited mode and highlight the essential role of the FA pathway in maintaining ovarian function.

Gynecology and Obstetrics Clinical MedicineVol. 5(2)
Shandong University (CN), Weifang People's Hospital (CN)
Shandong University, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, National Key Research and Development Program of China, Northwest Fisheries Science Center
Openalex Percentile: Top 86%
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.